Synthesis 2024; 56(04): 549-552
DOI: 10.1055/s-0042-1751470
special topic
Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)

An Alternative Formal Synthesis of (S)-(+)-Vigabatrin

Authors

  • Sudhir P. Chaskar

    a   API R & D Centre, Emcure Pharmaceuticals Ltd., ITBT Park, Phase-II, MIDC, Hinjewadi, Pune-411057, Maharashtra, India
  • Ramchandra Honparkhe

    a   API R & D Centre, Emcure Pharmaceuticals Ltd., ITBT Park, Phase-II, MIDC, Hinjewadi, Pune-411057, Maharashtra, India
  • Arvind K. Aghao

    b   Belbhim College, Department of Chemistry, Beed, Maharashtra, India
  • Rakesh G. Thorat

    a   API R & D Centre, Emcure Pharmaceuticals Ltd., ITBT Park, Phase-II, MIDC, Hinjewadi, Pune-411057, Maharashtra, India
  • Chinmoy Pramanik

    a   API R & D Centre, Emcure Pharmaceuticals Ltd., ITBT Park, Phase-II, MIDC, Hinjewadi, Pune-411057, Maharashtra, India


Graphical Abstract

Preview

Abstract

An improved synthesis of chirally pure advanced pyrrolidone intermediate of the (S)-(+)-vigabatrin, an antiseizure active pharmaceutical ingredient (API) is reported. The synthesis is developed using commercially available, cheaper amino acid (R)-methionine. Meldrum’s acid served as a two-carbon homologation unit to access the pyrrolidone intermediate in a short synthetic sequence. The sequence to pyrrolidone intermediate is scalable and eludes the use of organometallic pyrophoric reagents on a large scale.

Supporting Information



Publication History

Received: 17 March 2023

Accepted after revision: 07 June 2023

Article published online:
03 July 2023

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany